Transporters in Drug Discovery and Development
Autor Yurong Laien Limba Engleză Hardback – 2026
- Updated with new developments in transporter research, including the use of transporters as pharmacological targets, modeling and simulation, and endogenous biomarkers to assess transporter activities in drug clinical trials
- Covers tools and models that facilitate the evaluation and prediction of transporter-mediated activity
- Describes the transporters implications for the broader fields of medicine and pharmacology
- Provides foundational content on transporters' functions and roles in ADME-PK and toxicity
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Hardback (2) | 1233.93 lei 36-50 zile | +353.83 lei 6-12 zile |
| ELSEVIER SCIENCE – 31 oct 2013 | 1233.93 lei 36-50 zile | +353.83 lei 6-12 zile |
| ELSEVIER SCIENCE – 2026 | 1291.15 lei Precomandă |
Preț: 1291.15 lei
Preț vechi: 1359.11 lei
-5% Precomandă
Puncte Express: 1937
Preț estimativ în valută:
228.51€ • 267.98$ • 200.35£
228.51€ • 267.98$ • 200.35£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443364556
ISBN-10: 0443364559
Pagini: 750
Dimensiuni: 152 x 229 mm
Ediția:2nd edition
Editura: ELSEVIER SCIENCE
ISBN-10: 0443364559
Pagini: 750
Dimensiuni: 152 x 229 mm
Ediția:2nd edition
Editura: ELSEVIER SCIENCE
Cuprins
1. Membrane transporters and the diseases corresponding to functional defects
2. P-glycoprotein (P-gp/MDR1)/ABCB1
3. Multidrug resistance-associated protein 2 (MRP2/ABCC2)
4. Breast cancer resistance protein (BCRP)/ABCG2
5. The bile salt hemostasis transporters: BSEP/ABCB11, NTCP, OSTa/b, ASBT and MDR3
6. Organic anion- transporting polypeptides (OATPs/SLCOs)
7. Organic anion, organic cation, and zwitterion transporters of the SLC22 and SLC47 superfamily (OATs, OCTs, OCTNs, and MATEs)
8. Drug transporters in drug discovery and development.
9. Transporter study methodologies.
10. Transporters as pharmacological targets
11. Transporter endogenous substrates as biomarkers for transporter activities
12. Pharmacokinetics model analysis for transporter-mediated drug disposition and clearance.
2. P-glycoprotein (P-gp/MDR1)/ABCB1
3. Multidrug resistance-associated protein 2 (MRP2/ABCC2)
4. Breast cancer resistance protein (BCRP)/ABCG2
5. The bile salt hemostasis transporters: BSEP/ABCB11, NTCP, OSTa/b, ASBT and MDR3
6. Organic anion- transporting polypeptides (OATPs/SLCOs)
7. Organic anion, organic cation, and zwitterion transporters of the SLC22 and SLC47 superfamily (OATs, OCTs, OCTNs, and MATEs)
8. Drug transporters in drug discovery and development.
9. Transporter study methodologies.
10. Transporters as pharmacological targets
11. Transporter endogenous substrates as biomarkers for transporter activities
12. Pharmacokinetics model analysis for transporter-mediated drug disposition and clearance.